Anticoagulant Reversal Drugs Market
Anticoagulant Reversal Drugs Market Forecast by Product (Prothrombin Complex Concentrates, Vitamin K, Protamine, Tranexamic Acid, Idarucizumab, Andexxa), by Distribution Channel (Hospital, Retail Pharmacies), & by Region - Global Insights 2023 to 2033
Analysis of Anticoagulant Reversal Drugs market covering 30 + countries including analysis of US, Canada, UK, Germany, France, Nordics, GCC countries, Japan, Korea and many more
Table of Content
1. Preface 1.1. Report Scope and Market Segmentation 1.2. Research Highlights 2. Assumptions and Acronyms Used 3. Research Methodology 4. Executive Summary 5. Market Overview 5.1. Product Overview 5.2. Market Dynamics 5.2.1. Drivers 5.2.1.1. Rise in the prevalence of atrial fibrillation in aging population 5.2.1.2. Increase in the prevalence of ICH and GI hemorrhages 5.2.1.3. NTAP status for specific drugs 5.2.2. Restraints 5.2.2.1. Challenges associated with the development of anticoagulant reversal drugs 5.2.2.2. Risk associated with reversing anticoagulation 5.2.3. Opportunities 5.2.3.1. Unmet clinical needs 5.2.3.2. Untapped market in emerging economies 5.2.4. Global Anticoagulant Reversal Drugs Market Value (US$ Mn) Forecast, 2023-2033 5.2.5. Global Anticoagulant Reversal Drugs Market Outlook 5.2.6. Key Industry Developments 5.2.7. Regulatory Scenario 5.2.8. Reimbursement Scenario 5.2.9. Pipeline Analysis 5.2.10. Healthcare Overview 6. Global Anticoagulant Reversal Drugs Market Analysis, by Product 6.1. Introduction 6.2. Global Anticoagulant Reversal Drugs Market Value Share Analysis, by Product 6.3. Global Anticoagulant Reversal Drugs Market Value Forecast, by Product, 2023-2033 6.3.1. Prothrombin Complex Concentrates (PCC) 6.3.2. Vitamin K 6.3.3. Protamine 6.3.4. Tranexmic Acid 6.3.5. Idarucizumab 6.3.6. Andexxa 6.3.7. Others 6.4. Market Attractiveness, by Product 7. Global Anticoagulant Reversal Drugs Market Analysis, by Distribution Channel 7.1. Introduction 7.2. Global Anticoagulant Reversal Drugs Market Value Share Analysis, by Distribution Channel 7.3. Global Anticoagulant Reversal Drugs Market Value Forecast, by Distribution Channel, 2022-2032 7.3.1. Hospital Pharmacies 7.3.2. Retail Pharmacies 7.3.3. Others 7.4. Market Attractiveness, by Distribution Channel 8. Global Anticoagulant Reversal Drugs Market Analysis, by Region 8.1. Introduction 8.2. Global Anticoagulant Reversal Drugs Market Value Share Analysis, by Region 8.2.1. North America 8.2.2. Europe 8.2.3. Asia Pacific 8.2.4. Latin America 8.2.5. Middle East & Africa 8.3. Market Attractiveness Analysis, by Region 9. North America Anticoagulant Reversal Drugs Market Analysis 9.1. Key Findings 9.2. North America Anticoagulant Reversal Drugs Market Value Forecast, by Country, 2023-2033 9.2.1. U.S. 9.2.2. Canada 9.3. North America Anticoagulant Reversal Drugs Market Value Forecast, by Product, 2022-2032 9.3.1. Prothrombin Complex Concentrates (PCC) 9.3.2. Vitamin K 9.3.3. Protamine 9.3.4. Tranexmic Acid 9.3.5. Idarucizumab 9.3.6. Andexxa 9.3.7. Others 9.4. North America Anticoagulant Reversal Drugs Market Value Forecast, by Distribution Channel, 2022-2032 9.4.1. Hospital Pharmacies 9.4.2. Retail Pharmacies 9.4.3. Others 9.5. North America Market Attractiveness Analysis 9.5.1. By Country 9.5.2. By Product 9.5.3. By Distribution Channel 10. Europe Anticoagulant Reversal Drugs Market Analysis 10.1. Key Findings 10.2. Europe Anticoagulant Reversal Drugs Market Value Forecast, by Country/Sub-region, 2023-2033 10.2.1. U.K. 10.2.2. Germany 10.2.3. France 10.2.4. Italy 10.2.5. Spain 10.2.6. Rest of Europe 10.3. Europe Anticoagulant Reversal Drugs Market Value Forecast, by Product, 2022-2032 10.3.1. Prothrombin Complex Concentrates (PCC) 10.3.2. Vitamin K 10.3.3. Protamine 10.3.4. Tranexmic Acid 10.3.5. Idarucizumab 10.3.6. Andexxa 10.3.7. Others 10.4. Europe Anticoagulant Reversal Drugs Market Value Forecast, by Distribution Channel, 2022-2032 10.4.1. Hospital Pharmacies 10.4.2. Retail Pharmacies 10.4.3. Others 10.5. Europe Market Attractiveness Analysis 10.5.1. By Country/Sub-region 10.5.2. By Product 10.5.3. By Distribution Channel 11. Asia Pacific Anticoagulant Reversal Drugs Market Analysis 11.1. Key Findings 11.2. Asia Pacific Anticoagulant Reversal Drugs Market Value Forecast, by Country/Sub-region, 2023-2033 11.2.1. China 11.2.2. Japan 11.2.3. India 11.2.4. Australia 11.2.5. Rest of Asia Pacific 11.3. Asia Pacific Anticoagulant Reversal Drugs Market Value Forecast, by Product, 2022-2032 11.3.1. Prothrombin Complex Concentrates (PCC) 11.3.2. Vitamin K 11.3.3. Protamine 11.3.4. Tranexmic Acid 11.3.5. Idarucizumab 11.3.6. Andexxa 11.3.7. Others 11.4. Asia Pacific Anticoagulant Reversal Drugs Market Value Forecast, by Distribution Channel, 2022-2032 11.4.1. Hospital Pharmacies 11.4.2. Retail Pharmacies 11.4.3. Others 11.5. Asia Pacific Market Attractiveness Analysis 11.5.1. By Country/Sub-region 11.5.2. By Product 11.5.3. By Distribution Channel 12. Latin America Anticoagulant Reversal Drugs Market Analysis 12.1. Key Findings 12.2. Latin America Anticoagulant Reversal Drugs Market Value Forecast, by Country/Sub-region, 2023-2033 12.2.1. Brazil 12.2.2. Mexico 12.2.3. Rest of Latin America 12.3. Latin America Anticoagulant Reversal Drugs Market Value Forecast, by Product, 2022-2032 12.3.1. Prothrombin Complex Concentrates (PCC) 12.3.2. Vitamin K 12.3.3. Protamine 12.3.4. Tranexmic Acid 12.3.5. Idarucizumab 12.3.6. Andexxa 12.3.7. Others 12.4. Latin America Anticoagulant Reversal Drugs Market Value Forecast, by Distribution Channel, 2022-2032 12.4.1. Hospital Pharmacies 12.4.2. Retail Pharmacies 12.4.3. Others 12.5. Latin America Market Attractiveness Analysis 12.5.1. By Country/Sub-region 12.5.2. By Product 12.5.3. By Distribution Channel 13. Middle East & Africa Anticoagulant Reversal Drugs Market Analysis 13.1. Key Findings 13.2. Middle East & Africa Anticoagulant Reversal Drugs Market Value Forecast, by Country/Sub-region, 2023-2033 13.2.1. GCC Countries 13.2.2. South Africa 13.2.3. Israel 13.2.4. Rest of Middle East & Africa 13.3. Middle East & Africa Anticoagulant Reversal Drugs Market Value Forecast, by Product, 2022-2032 13.3.1. Prothrombin Complex Concentrates (PCC) 13.3.2. Vitamin K 13.3.3. Protamine 13.3.4. Tranexmic Acid 13.3.5. Idarucizumab 13.3.6. Andexxa 13.3.7. Others 13.4. Middle East & Africa Anticoagulant Reversal Drugs Market Value Forecast, by Distribution Channel, 2022-2032 13.4.1. Hospital Pharmacies 13.4.2. Retail Pharmacies 13.4.3. Others 13.5. Middle East & Africa Market Attractiveness Analysis 13.5.1. By Country/Sub-region 13.5.2. By Product 13.5.3. By Distribution Channel 14. Competitive Landscape 14.1. Competition Matrix 14.2. Anticoagulant Reversal Drugs Market Share Analysis, by Company (2023) 14.3. Company Profiles 14.3.1. Bausch Health Companies, Inc. 14.3.1.1. Company Overview (Headquarters, Business Segments, Employee Strength) 14.3.1.2. Financial Overview 14.3.1.3. Product Portfolio 14.3.1.4. SWOT Analysis 14.3.1.5. Strategic Overview 14.3.2. Pfizer, Inc. 14.3.2.1. Company Overview (Headquarters, Business Segments, Employee Strength) 14.3.2.2. Financial Overview 14.3.2.3. Product Portfolio 14.3.2.4. SWOT Analysis 14.3.2.5. Strategic Overview 14.3.3. Fresenius Kabi AG 14.3.3.1. Company Overview (Headquarters, Business Segments, Employee Strength) 14.3.3.2. Financial Overview 14.3.3.3. Product Portfolio 14.3.3.4. SWOT Analysis 14.3.3.5. Strategic Overview 14.3.4. Amneal Pharmaceuticals, Inc. 14.3.4.1. Company Overview (Headquarters, Business Segments, Employee Strength) 14.3.4.2. Financial Overview 14.3.4.3. Product Portfolio 14.3.4.4. SWOT Analysis 14.3.4.5. Strategic Overview 14.3.5. Boehringer Ingelheim GmbH 14.3.5.1. Company Overview (Headquarters, Business Segments, Employee Strength) 14.3.5.2. Financial Overview 14.3.5.3. Product Portfolio 14.3.5.4. SWOT Analysis 14.3.5.5. Strategic Overview 14.3.6. CSL Limited 14.3.6.1. Company Overview (Headquarters, Business Segments, Employee Strength) 14.3.6.2. Financial Overview 14.3.6.3. Product Portfolio 14.3.6.4. SWOT Analysis 14.3.6.5. Strategic Overview 14.3.7. Octapharma AG 14.3.7.1. Company Overview (Headquarters, Business Segments, Employee Strength) 14.3.7.2. Financial Overview 14.3.7.3. Product Portfolio 14.3.7.4. SWOT Analysis 14.3.7.5. Strategic Overview 14.3.8. Portola Pharmaceuticals, Inc. 14.3.8.1. Company Overview (Headquarters, Business Segments, Employee Strength) 14.3.8.2. Financial Overview 14.3.8.3. Product Portfolio 14.3.8.4. SWOT Analysis 14.3.8.5. Strategic Overview 14.3.9. Perosphere Pharmaceuticals, Inc. (acquired by AMAG Pharmaceuticals, Inc.) 14.3.9.1. Company Overview (Headquarters, Business Segments, Employee Strength) 14.3.9.2. Financial Overview 14.3.9.3. Product Portfolio 14.3.9.4. SWOT Analysis 14.3.9.5. Strategic Overview
Don't Need a Global Report?
save 40%! on Country & Region specific reports
List Of Table
Table 01: Reimbursement Scenario for AndeXXa
Table 02: Reimbursement Scenario for Praxbind
Table 03: Reimbursement Scenario for Kcentra
Table 04: Pipeline Analysis
Table 05: Global Anticoagulant Reversal Drugs Market Revenue (US$ Mn) Forecast, by Product, 2022-2032
Table 06: Global Anticoagulant Reversal Drugs Market Revenue (US$ Mn) Forecast, by Distribution Channel, 2022-2032
Table 07: Global Anticoagulant Reversal Drugs Market Revenue (US$ Mn) Forecast, by Region, 2022-2032
Table 08: North America Anticoagulant Reversal Drugs Market Revenue (US$ Mn) Forecast, by Country, 2022-2032
Table 09: North America Anticoagulant Reversal Drugs Market Revenue (US$ Mn) Forecast, by Product, 2022-2032
Table 10: North America Anticoagulant Reversal Drugs Market Revenue (US$ Mn) Forecast, by Distribution Channel, 2022-2032
Table 11: Europe Anticoagulant Reversal Drugs Market Revenue (US$ Mn) Forecast, by Country/Sub-region, 2022-2032
Table 12: Europe Anticoagulant Reversal Drugs Market Revenue (US$ Mn) Forecast, by Product, 2022-2032
Table 13: Europe Anticoagulant Reversal Drugs Market Revenue (US$ Mn) Forecast, by Distribution Channel, 2022-2032
Table 14: Asia Pacific Anticoagulant Reversal Drugs Market Revenue (US$ Mn) Forecast, by Country/Sub-region, 2022-2032
Table 15: Asia Pacific Anticoagulant Reversal Drugs Market Revenue (US$ Mn) Forecast, by Product, 2022-2032
Table 16: Asia Pacific Anticoagulant Reversal Drugs Market Revenue (US$ Mn) Forecast, by Distribution Channel, 2022-2032
Table 17: Latin America Anticoagulant Reversal Drugs Market Revenue (US$ Mn) Forecast, by Country/Sub-region, 2022-2032
Table 18: Latin America Anticoagulant Reversal Drugs Market Revenue (US$ Mn) Forecast, by Product, 2022-2032
Table 19: Latin America Anticoagulant Reversal Drugs Market Revenue (US$ Mn) Forecast, by Distribution Channel, 2022-2032
Table 20: Middle East & Africa Anticoagulant Reversal Drugs Market Revenue (US$ Mn) Forecast, by Country/Sub-region, 2022-2032
Table 21: Middle East & Africa Anticoagulant Reversal Drugs Market Revenue (US$ Mn) Forecast, by Product, 2022-2032
Table 22: Middle East & Africa Anticoagulant Reversal Drugs Market Revenue (US$ Mn) Forecast, by Distribution Channel, 2022-2032
More Insights, Lesser Cost (-50% off)
Insights on import/export production,
pricing analysis, and more – Only @ Fact.MR
List Of Figures
Figure 01: Anticoagulant Reversal Drugs Market Size (US$ Mn) and Distribution, by Region, 2023 and 2033
Figure 02: Global Anticoagulant Reversal Drugs Market Size (US$ Mn) and Forecast, 2022-2032
Figure 03: Market Value Share, by Product (2023)
Figure 04: Market Value Share, by Distribution Channel (2023)
Figure 05: Market Value Share, by Region (2023)
Figure 06: Regulatory Approval Process - U.S.
Figure 07: Regulatory Approval Process - Europe
Figure 08: Regulatory Approval Process - Japan
Figure 09: Global Anticoagulant Reversal Drugs Market Value Share Analysis, by Product, 2023 and 2033
Figure 10: Global Anticoagulant Reversal Drugs Market Revenue (US$ Mn) Forecast and Y-o-Y Growth (%), by Prothrombin Complex Concentrates (PCC) 2022-2032
Figure 11: Global Anticoagulant Reversal Drugs Market Revenue (US$ Mn) Forecast and Y-o-Y Growth (%), by Vitamin K, 2022-2032
Figure 12: Global Anticoagulant Reversal Drugs Market Revenue (US$ Mn) Forecast and Y-o-Y Growth (%), by Protamine, 2022-2032
Figure 13: Global Anticoagulant Reversal Drugs Market Revenue (US$ Mn) Forecast and Y-o-Y Growth (%), by Tranexamic Acid, 2022-2032
Figure 14: Global Anticoagulant Reversal Drugs Market Revenue (US$ Mn) Forecast and Y-o-Y Growth (%), by Others, 2022-2032
Figure 15: Global Anticoagulant Reversal Drugs Market Revenue (US$ Mn) Forecast and Y-o-Y Growth (%), by Idarucizumab, 2022-2032
Figure 16: Global Anticoagulant Reversal Drugs Market Revenue (US$ Mn) Forecast and Y-o-Y Growth (%), by AndeXXa, 2022-2032
Figure 17: Global Anticoagulant Reversal Drugs Market Attractiveness Analysis, by Product, 2022-2032
Figure 18: Global Anticoagulant Reversal Drugs Market Value Share Analysis, by Distribution Channel, 2023 and 2033
Figure 19: Global Anticoagulant Reversal Drugs Market Attractiveness Analysis, by Distribution Channel, 2022-2032
Figure 20: Global Anticoagulant Reversal Drugs Market Revenue (US$ Mn) Forecast and Y-o-Y Growth (%), by Hospital Pharmacies, 2022-2032
Figure 21: Global Anticoagulant Reversal Drugs Market Revenue (US$ Mn) Forecast and Y-o-Y Growth (%), by Retail Pharmacies, 2022-2032
Figure 22: Global Anticoagulant Reversal Drugs Market Revenue (US$ Mn) Forecast and Y-o-Y Growth (%), by Others, 2022-2032
Figure 23: Global Anticoagulant Reversal Drugs Market Value Share, by Region, 2023 and 2033
Figure 24: Global Anticoagulant Reversal Drugs Market Attractiveness, by Region, 2022-2032
Figure 25: North America Anticoagulant Reversal Drugs Market Revenue (US$ Mn) and Y-o-Y Growth (%) Forecast, 2022-2032
Figure 26: North America Anticoagulant Reversal Drugs Market Value Share Analysis, by Country, 2023 and 2033
Figure 27: North America Anticoagulant Reversal Drugs Market Attractiveness Analysis, by Country, 2023-2033
Figure 28: North America Anticoagulant Reversal Drugs Market Value Share Analysis, by Product, 2023 and 2033
Figure 29: North America Anticoagulant Reversal Drugs Market Attractiveness Analysis, by Product, 2022-2032
Figure 30: North America Anticoagulant Reversal Drugs Market Value Share Analysis, by Distribution Channel, 2023 and 2033
Figure 31: North America Anticoagulant Reversal Drugs Market Attractiveness Analysis, by Distribution Channel, 2022-2032
Figure 32: Europe Anticoagulant Reversal Drugs Market Revenue (US$ Mn) and Y-o-Y Growth (%) Forecast, 2022-2032
Figure 33: Europe Anticoagulant Reversal Drugs Market Value Share Analysis, by Country/Sub-region, 2023 and 2033
Figure 34: Europe Anticoagulant Reversal Drugs Market Attractiveness Analysis, by Country/Sub-region, 2023-2033
Figure 35: Europe Anticoagulant Reversal Drugs Market Value Share Analysis, by Product, 2023 and 2033
Figure 36: Europe Anticoagulant Reversal Drugs Market Attractiveness Analysis, by Product, 2022-2032
Figure 37: Europe Anticoagulant Reversal Drugs Market Value Share Analysis, by Distribution Channel, 2023 and 2033
Figure 38: Europe Anticoagulant Reversal Drugs Market Attractiveness Analysis, by Distribution Channel, 2022-2032
Figure 39: Asia Pacific Anticoagulant Reversal Drugs Market Revenue (US$ Mn) and Y-o-Y Growth (%) Forecast, 2022-2032
Figure 40: Asia Pacific Anticoagulant Reversal Drugs Market Value Share Analysis, by Country/Sub-region, 2023 and 2033
Figure 41: Asia Pacific Anticoagulant Reversal Drugs Market Attractiveness Analysis, by Country/Sub-region, 2022-2032
Figure 42: Asia Pacific Anticoagulant Reversal Drugs Market Value Share Analysis, by Product, 2023 and 2033
Figure 43: Asia Pacific Anticoagulant Reversal Drugs Market Attractiveness Analysis, by Product, 2022-2032
Figure 44: Asia Pacific Anticoagulant Reversal Drugs Market Value Share Analysis, by Distribution Channel, 2023 and 2033
Figure 45: Asia Pacific Anticoagulant Reversal Drugs Market Attractiveness Analysis, by Distribution Channel, 2022-2032
Figure 46: Latin America Anticoagulant Reversal Drugs Market Revenue (US$ Mn) and Y-o-Y Growth (%) Forecast, 2022-2032
Figure 47: Latin America Anticoagulant Reversal Drugs Market Value Share Analysis, by Country/Sub-region, 2023 and 2033
Figure 48: Latin America Anticoagulant Reversal Drugs Market Attractiveness Analysis, by Country/Sub-region, 2022-2032
Figure 49: Latin America Anticoagulant Reversal Drugs Market Value Share Analysis, by Product, 2023 and 2033
Figure 50: Latin America Anticoagulant Reversal Drugs Market Attractiveness Analysis, by Product, 2022-2032
Figure 51: Latin America Anticoagulant Reversal Drugs Market Value Share Analysis, by Distribution Channel, 2023 and 2033
Figure 52: Latin America Anticoagulant Reversal Drugs Market Attractiveness Analysis, by Distribution Channel, 2022-2032
Figure 53: Middle East & Africa Anticoagulant Reversal Drugs Market Revenue (US$ Mn) and Y-o-Y Growth (%) Forecast, 2022-2032
Figure 54: Middle East & Africa Anticoagulant Reversal Drugs Market Value Share Analysis, by Country/Sub-region, 2023 and 2033
Figure 55: Middle East & Africa Anticoagulant Reversal Drugs Market Attractiveness Analysis, by Country/Sub-region, 2022-2032
Figure 56: Middle East & Africa Anticoagulant Reversal Drugs Market Value Share Analysis, by Product, 2023 and 2033
Figure 57: Middle East & Africa Anticoagulant Reversal Drugs Market Attractiveness Analysis, by Product, 2022-2032
Figure 58: Middle East & Africa Anticoagulant Reversal Drugs Market Value Share Analysis, by Distribution Channel, 2023 and 2033
Figure 59: Middle East & Africa Anticoagulant Reversal Drugs Market Attractiveness Analysis, by Distribution Channel, 2022-2032
Figure 60: Global Anticoagulant Reversal Drugs Market Share Analysis, by Company (2023)
Figure 61: Product Overview - Bausch Health Companies, Inc.
Figure 62: Breakdown of Net Sales (%), by Region, 2023 - Bausch Health Companies, Inc.
Figure 63: Revenue (US$ Mn), 2017–2022 - Bausch Health Companies, Inc.
Figure 64: R&D Expenses (US$ Mn), 2023-2033 - Bausch Health Companies, Inc.
Figure 65: Product Overview - Pfizer, Inc.
Figure 66: Breakdown of Net Sales, by Region, 2023 - Pfizer, Inc.
Figure 67: Revenue (US$ Bn) and Y-o-Y Growth (%), 2017–2022 - Pfizer, Inc.
Figure 68: R&D Intensity and Sales & Marketing Intensity - Company Level, 2022-2032 - Pfizer, Inc.
Figure 69: Product Overview - Fresenius Kabi AG
Figure 70: Revenue (US$ Mn) & Y-o-Y Growth (%), 2022-2032 - Fresenius Kabi AG
Figure 71: Breakdown of Net Sales, by Region, 2017 - Fresenius Kabi AG
Figure 72: Breakdown of Net Sales, by Segment, 2017 - Fresenius Kabi AG
Figure 73: Research & Development Cost, 2023 - 2033 (US$ Mn) - Fresenius Kabi AG
Figure 74: Product Overview - Amneal Pharmaceuticals, Inc.
Figure 75: Product Overview - Boehringer Ingelheim GmbH
Figure 76: Revenue (US$ Bn) and Y-o-Y Growth (%), 2022-2032 - Boehringer Ingelheim GmbH
Figure 77: Breakdown of Net Sales, by Business and Business Segment Level, 2023 - Boehringer Ingelheim GmbH
Figure 78: Breakdown of Net Sales, by Region (Company Level), 2023 - Boehringer Ingelheim GmbH
Figure 79: R&D Expenditure (US$ Bn), 2017–2022 - Boehringer Ingelheim GmbH
Figure 80: Product Overview: CSL Limited
Figure 81: Total Revenue (US$ Mn) and Y-o-Y Growth, 2022-2032 – CSL Limited
Figure 82: R&D Investment, (US$ Mn) and Y-o-Y Growth, 2022-2032 - CSL Limited
Figure 83: Sales Revenue (US$ Mn) and Y-o-Y Growth, 2022-2032 - CSL Limited
Figure 84: Net Profit (US$ Mn), 2022-2032 - CSL Limited
Figure 85: Product Overview - Octapharma AG
Figure 86: Revenue (US$ Mn) and Y-o-Y Growth, 2017–2022 - Octapharma AG
Figure 87: R&D and Selling and Marketing Expenses, (US$ Mn), 2022-2032 - Octapharma AG
Figure 88: Year-end Employee Headcount and Y-o-Y Growth, 2023-2033 - Octapharma AG
Figure 89: Gross profit (US$ Mn) and Y-o-Y Growth, 2022-2032 - Octapharma AG
Figure 90: Product Overview - Portola Pharmaceuticals, Inc.
Figure 91: R&D and Selling and Marketing Expenses, (US$ Mn), 2022-2032 - Portola Pharmaceuticals, Inc.
Figure 92: Revenue (US$ Mn) and Y-o-Y Growth, 2017–2022 - Portola Pharmaceuticals, Inc.
Figure 93: Product Overview - Perosphere Pharmaceuticals Inc.
Know thy Competitors
Competitive landscape highlights only certain players
Complete list available upon request